News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
STIGALL L. JEREMY
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/07/2023 |
4
| STIGALL L. JEREMY (GM, Biologics & Drug Delivery) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Paid exercise price by delivering 1,730 shares
@ $6.53, valued at
$11.3k
|
|
| 07/05/2023 |
4
| STIGALL L. JEREMY (GM, Biologics & Drug Delivery) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 2,682 shares
@ $6.15, valued at
$16.5k
|
|
| 03/08/2023 |
4
| STIGALL L. JEREMY (GM, Biologics & Drug Delivery) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 14,814 options to buy
@ $8.1, valued at
$120k
Granted 44,444 restricted stock units
@ $0 |
|
| 02/23/2023 |
4
| STIGALL L. JEREMY (GM, Biologics & Drug Delivery) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Paid exercise price by delivering 514 shares
@ $8.55, valued at
$4.4k
|
|
| 01/30/2023 |
5
| STIGALL L. JEREMY (GM, Biologics & Drug Delivery) has filed a Form 5 on ClearPoint Neuro, Inc. |
| 08/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|